NTRK2 and Alzheimer disease: In addition to 7,8-DHF, Chen et al. also showed that a synthetic derivative CF3CN binds with TRKB, activates TRKB signaling, reduces AD pathologies, and ameliorates cognitive dysfunctions in 5XFAD mice [56].